
XWELL, Iovance Biotherapeutics, and MannKind are the three Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small or micro-cap companies—typically those trading for less than $5 per share under the SEC’s definition—and are often listed on over-the-counter markets rather than major exchanges. They are highly speculative: they tend to have low liquidity, wide price swings, and a greater risk of fraud or market manipulation compared with larger, exchange-listed stocks. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
XWELL (XWEL)
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products.
Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma.
Read Our Latest Research Report on IOVA
MannKind (MNKD)
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults.
Read Our Latest Research Report on MNKD
See Also
- MarketBeat’s Top Five Stocks to Own in February 2026
- IBM’s Steep Drop on AI Fears May Be an Overreaction
- DigitalOcean’s AI Surge: The Cloud Underdog Swims Upstream
- SoundHound’s New Sales Assist Agent Put Voice AI Back in the Spotlight
- Keurig Dr Pepper’s Split Plan Could Unlock Hidden Value
- Insiders Are Loading Up on 3 Small Caps—1 Looks Most Compelling
